Tissue study for people getting CAR-T cell therapy
Part of Cancer, Immune system & allergy clinical trials.
This study looks at tissue samples from adults who are receiving CAR-T cell therapy for blood-related conditions. It aims to learn more about how CAR-T works and what changes happen in the body, which may help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have a blood-related (hematologic) condition and be scheduled for CAR-T therapy at the Bologna Advanced Cell Therapy Program
- Be able to sign an informed consent form and agree to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a patient’s genetic (molecular) information while they receive CAR-T cell therapy. The goal is to better understand how different biological factors may affect CAR-T treatment.
This study tracks patients who have received CAR-T cell therapy to learn more about infections that may happen after treatment. It aims to improve care and outcomes for people with certain blood cancers.
This study will look at information from people with non-Hodgkin lymphoma who are getting CAR-T cell therapy (a treatment that uses your own immune cells to attack cancer). The goal is to create tools that help doctors predict how well the treatment will work and what side effects might happen, so they can better care for patients.
This study is for people with blood cancers who are treated with CAR-T cell therapy. Researchers will follow participants over time to learn more about how this therapy works in the real world.
This study looks at how your immune system responds to CAR-T cell therapy, a treatment that uses your own immune cells to fight certain cancers. By participating, you help researchers learn more about how this therapy affects the body, which could improve care for future patients.
This study collects blood and tissue samples from adults receiving CAR-T cell therapy (an advanced cancer treatment) to understand why it works well for some patients but not others. The goal is to find biological markers that predict treatment success.
Hear when a new CAR-T Therapy Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.